Charge Enterprises, Inc.

$ Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000165495422015114 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q4

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$34.48M	$42.64M	$27.86M
YoY Change	23.77%	90.74%	87.22%
Cash & Equivalents	$27.72M	$36.24M	$18.24M
Short-Term Investments	$6.757M	$6.405M	$9.619M
Other Short-Term Assets	$10.16M	$12.37M	$6.534M
YoY Change	55.55%	1032.36%
Inventory	$111.0K	$183.8K	$111.1K
Prepaid Expenses
Receivables	$72.41M	$74.98M	$73.33M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$116.5M	$130.3M	$107.9M
YoY Change	7.94%	64.89%	35.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$732.0K	$1.661M	$2.012M
YoY Change	-63.61%	-41.29%	13.39%
Goodwill	$12.67M	$36.02M	$26.05M
YoY Change	-51.36%		51.69%
Intangibles	$33.93M	$10.86M	$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets	$240.0K	$4.790M	$5.580M
YoY Change	-95.7%	-24.5%
Total Long-Term Assets	$51.95M	$57.19M	$35.67M
YoY Change	45.61%	144.79%	81.52%
TOTAL ASSETS
Total Short-Term Assets	$116.5M	$130.3M	$107.9M
Total Long-Term Assets	$51.95M	$57.19M	$35.67M
Total Assets	$168.5M	$187.5M	$143.6M
YoY Change	17.3%	83.12%	44.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$61.64M	$82.06M	$71.43M
YoY Change	-13.7%	28.69%	2.17%
Accrued Expenses	$11.12M	$10.00M	$5.739M
YoY Change	93.76%	278.81%	630.98%
Deferred Revenue	$13.74M
YoY Change
Short-Term Debt	$0.00	$2.152M	$1.898M
YoY Change	-100.0%	42.12%
Long-Term Debt Due	$29.18M	$134.1K	$2.860M
YoY Change	920.44%	-95.67%
Total Short-Term Liabilities	$123.9M	$116.5M	$89.07M
YoY Change	39.1%	63.94%	15.96%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$22.91M	$30.78M
YoY Change	-100.0%	61.68%
Other Long-Term Liabilities	$2.199M	$2.209M	$1.443M
YoY Change	52.42%	481.98%
Total Long-Term Liabilities	$0.00	$25.12M	$32.22M
YoY Change	-100.0%	72.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$123.9M	$116.5M	$89.07M
Total Long-Term Liabilities	$0.00	$25.12M	$32.22M
Total Liabilities	$127.6M	$141.6M	$121.3M
YoY Change	5.23%	65.42%	54.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$173.6M	-$161.2M	-$111.4M
YoY Change	55.84%		113.62%
Common Stock	$20.00K	$20.65K	$18.43K
YoY Change	8.54%		-86.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$24.25M	$16.57M	$15.47M
YoY Change
Total Liabilities & Shareholders Equity	$168.5M	$187.5M	$143.6M
YoY Change	17.3%	83.12%	44.47%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q4

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1059966	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10864651	usd
	crge	Less Unamortized Discount And Debt Issue Costs LessUnamortizedDiscountAndDebtIssueCosts	0	usd
CY2021	crge	Convertible Notes Payable Amount ConvertibleNotesPayableAmount	12565289	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2021	crge	Less Unamortized Discount And Debt Issue Costs LessUnamortizedDiscountAndDebtIssueCosts	-5389692	usd
	crge	Convertible Notes Payable Amount ConvertibleNotesPayableAmount	0	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	7175597	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	497053	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	604605	usd
CY2021Q3	crge	Accumulated Amortization Deferred Finance Costs1 AccumulatedAmortizationDeferredFinanceCosts1	0	usd
CY2021Q3	crge	Amortization Of Debt Discount1 AmortizationOfDebtDiscount1	912767	usd
	crge	Amortization Of Debt Discount1 AmortizationOfDebtDiscount1	5391022	usd
	crge	Amortization Of Debt Discount1 AmortizationOfDebtDiscount1	1895555	usd
	crge	Accumulated Amortization Deferred Finance Costs1 AccumulatedAmortizationDeferredFinanceCosts1	7397	usd
CY2021Q3	crge	Total total	1172602	usd
	crge	Total total	5888075	usd
	crge	Total total	2507557	usd
	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	0	usd
CY2021	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	183067	usd
CY2020Q3	crge	Warrants Warrants	658667	usd
CY2022Q3	crge	Korr Value Converted KorrValueConverted	261111	usd
	crge	Capital Expenditures CapitalExpenditures	1274687	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001277250
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	206482414	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	184266934	shares
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
CY2022Q3	crge	Amortization Of Debt Discount1 AmortizationOfDebtDiscount1	0	usd
CY2022Q3	crge	Accumulated Amortization Deferred Finance Costs1 AccumulatedAmortizationDeferredFinanceCosts1	0	usd
CY2022Q3	crge	Paycheck Protection Program Loan PaycheckProtectionProgramLoan	0	usd
CY2021Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2021Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	0	shares
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	0	shares
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	0	shares
	crge	Warrant Warrant	0	shares
CY2021Q3	crge	Warrant Warrant	0	shares
	crge	Warrant Warrant	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41354
	dei	Entity Registrant Name EntityRegistrantName	CHARGE ENTERPRISES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-0471969
	dei	Entity Address Address Line1 EntityAddressAddressLine1	125 Park Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	25th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10017
	dei	City Area Code CityAreaCode	212
	dei	Local Phone Number LocalPhoneNumber	921-2100
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001
	dei	Trading Symbol TradingSymbol	CRGE
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	206644914	shares
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36235710	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18238264	usd
CY2022Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	171078	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	176949	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	74984606	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	73334183	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	183849	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	111070	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4511644	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1721222	usd
CY2022Q3	us-gaap	Marketable Securities MarketableSecurities	6404567	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	9618743	usd
CY2022Q3	crge	Investment In Non Marketable Securities InvestmentInNonMarketableSecurities	175416	usd
CY2021Q4	crge	Investment In Non Marketable Securities InvestmentInNonMarketableSecurities	100000	usd
CY2022Q3	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs CostsInExcessOfBillingsOnUncompletedContractsOrPrograms	7853793	usd
CY2021Q4	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs CostsInExcessOfBillingsOnUncompletedContractsOrPrograms	4812483	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	130349585	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	107935965	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1661043	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2011668	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10864651	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	390345	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	469645	usd
CY2022Q3	crge	Right Of Use Asset RightOfUseAsset	3471459	usd
CY2021Q4	crge	Right Of Use Asset RightOfUseAsset	1558052	usd
CY2022Q3	us-gaap	Noncurrent Assets NoncurrentAssets	232000	usd
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	0	usd
CY2022Q3	us-gaap	Goodwill Goodwill	36017209	usd
CY2021Q4	us-gaap	Goodwill Goodwill	26054522	usd
CY2022Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4558166	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	5579660	usd
CY2022Q3	us-gaap	Assets Assets	187544458	usd
CY2021Q4	us-gaap	Assets Assets	143609512	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	82059741	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	71428301	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10000762	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5739475	usd
CY2022Q3	us-gaap	Deferred Revenue DeferredRevenue	9065856	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	7017392	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	11773452	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2022Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	2700337	usd
CY2022Q3	us-gaap	Line Of Credit LineOfCredit	2152388	usd
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	1898143	usd
CY2022Q3	crge	Finance Leases Liability FinanceLeasesLiability	134099	usd
CY2021Q4	crge	Finance Leases Liability FinanceLeasesLiability	159215	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1340849	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	125191	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	116527147	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	89068054	usd
CY2022Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	165653	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	218825	usd
CY2022Q3	crge	Operating Lease Liability Non Current OperatingLeaseLiabilityNonCurrent	2208909	usd
CY2021Q4	crge	Operating Lease Liability Non Current OperatingLeaseLiabilityNonCurrent	1442743	usd
CY2022Q3	us-gaap	Notes Payable NotesPayable	22747991	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	26087523	usd
CY2022Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	0	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	4475260	usd
CY2022Q3	us-gaap	Liabilities Liabilities	141649700	usd
CY2021Q4	us-gaap	Liabilities Liabilities	121292405	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	16571656	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	6850000	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	206482414	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	184266934	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	20648	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	18426	usd
CY2022Q3	crge	Common Stock To Be Issued CommonStockToBeIssued	0	shares
CY2021Q4	crge	Common Stock To Be Issued CommonStockToBeIssued	6587897	shares
CY2022Q3	crge	Common Stock To Be Issued Shares CommonStockToBeIssuedShares	0	usd
CY2021Q4	crge	Common Stock To Be Issued Shares CommonStockToBeIssuedShares	658	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	190521417	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	126869604	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Before Tax1 AccumulatedOtherComprehensiveIncomeLossBeforeTax1	0	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Before Tax1 AccumulatedOtherComprehensiveIncomeLossBeforeTax1	-32289	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-161219081	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-111389529	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29323102	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15467107	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	187544458	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	143609512	usd
CY2022Q3	us-gaap	Revenues Revenues	185857129	usd
CY2021Q3	us-gaap	Revenues Revenues	116998086	usd
	us-gaap	Revenues Revenues	529875631	usd
	us-gaap	Revenues Revenues	357708784	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	178950754	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	113094330	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	509218015	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	350079862	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	6906375	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	3903756	usd
	us-gaap	Gross Profit GrossProfit	20657616	usd
	us-gaap	Gross Profit GrossProfit	7628922	usd
CY2022Q3	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	7847636	usd
CY2021Q3	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	7557616	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	28351975	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	21351212	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3515727	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1928391	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10420242	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5324092	usd
CY2022Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4416656	usd
CY2021Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2586680	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	12786665	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5210140	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	667411	usd
CY2021Q3	us-gaap	Professional Fees ProfessionalFees	431698	usd
	us-gaap	Professional Fees ProfessionalFees	2580020	usd
	us-gaap	Professional Fees ProfessionalFees	1264299	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	432921	usd
CY2021Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	166431	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1745040	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	314334	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	16880351	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	12670816	usd
	us-gaap	Operating Expenses OperatingExpenses	55883942	usd
	us-gaap	Operating Expenses OperatingExpenses	33464077	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-9973976	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8767060	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-35226326	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-25835155	usd
CY2022Q3	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
CY2021Q3	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	-18119592	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	-18119592	usd
CY2022Q3	us-gaap	Net Investment Income NetInvestmentIncome	-117715	usd
CY2021Q3	us-gaap	Net Investment Income NetInvestmentIncome	-840911	usd
	us-gaap	Net Investment Income NetInvestmentIncome	-1140090	usd
	us-gaap	Net Investment Income NetInvestmentIncome	3420417	usd
CY2022Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	494561	usd
CY2021Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-1164806	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-7938229	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-2147594	usd
CY2022Q3	crge	Amortization Of Debt Discount Related Party AmortizationOfDebtDiscountRelatedParty	0	usd
CY2021Q3	crge	Amortization Of Debt Discount Related Party AmortizationOfDebtDiscountRelatedParty	0	usd
	crge	Amortization Of Debt Discount Related Party AmortizationOfDebtDiscountRelatedParty	0	usd
	crge	Amortization Of Debt Discount Related Party AmortizationOfDebtDiscountRelatedParty	-95127	usd
CY2022Q3	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	28669066	usd
CY2021Q3	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	0	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	28669066	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-400	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	520834	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	485542	usd
	us-gaap	Interest Expense InterestExpense	2001615	usd
	us-gaap	Interest Expense InterestExpense	934225	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3346462	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1181781	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2432871	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1171343	usd
CY2022Q3	crge	Foreign Exchange Adjustments ForeignExchangeAdjustments	-24347	usd
CY2021Q3	crge	Foreign Exchange Adjustments ForeignExchangeAdjustments	251280	usd
	crge	Foreign Exchange Adjustments ForeignExchangeAdjustments	-110538	usd
	crge	Foreign Exchange Adjustments ForeignExchangeAdjustments	-261432	usd
CY2022Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	24165147	usd
CY2021Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-19177790	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	15045723	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-16966610	usd
CY2022Q3	us-gaap	Income Loss From Subsidiaries Tax Expense Benefit IncomeLossFromSubsidiariesTaxExpenseBenefit	14191171	usd
CY2021Q3	us-gaap	Income Loss From Subsidiaries Tax Expense Benefit IncomeLossFromSubsidiariesTaxExpenseBenefit	-27944850	usd
	us-gaap	Income Loss From Subsidiaries Tax Expense Benefit IncomeLossFromSubsidiariesTaxExpenseBenefit	-20180603	usd
	us-gaap	Income Loss From Subsidiaries Tax Expense Benefit IncomeLossFromSubsidiariesTaxExpenseBenefit	-42801765	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	183184	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2715260	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1772804	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5908091	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	14374355	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-25229590	usd
	us-gaap	Net Income Loss NetIncomeLoss	-18407799	usd
	us-gaap	Net Income Loss NetIncomeLoss	-36893674	usd
CY2022Q3	crge	Less Deemed Dividend LessDeemedDividend	0	usd
CY2021Q3	crge	Less Deemed Dividend LessDeemedDividend	0	usd
	crge	Less Deemed Dividend LessDeemedDividend	-36697317	usd
	crge	Less Deemed Dividend LessDeemedDividend	0	usd
CY2022Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	302441	usd
CY2021Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	922254	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	usd
CY2022Q3	crge	Net Income Loss Available To Common Stockholders NetIncomeLossAvailableToCommonStockholders	14071914	usd
CY2021Q3	crge	Net Income Loss Available To Common Stockholders NetIncomeLossAvailableToCommonStockholders	-25229590	usd
	crge	Net Income Loss Available To Common Stockholders NetIncomeLossAvailableToCommonStockholders	-56027370	usd
	crge	Net Income Loss Available To Common Stockholders NetIncomeLossAvailableToCommonStockholders	-36893674	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	206224561	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	152222589	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	196126428	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	150397062	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	231388387	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	152222589	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	196126428	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	150397062	shares
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	14374355	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-25229590	usd
	us-gaap	Net Income Loss NetIncomeLoss	-18407799	usd
	us-gaap	Net Income Loss NetIncomeLoss	-36893674	usd
CY2022Q3	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	32859	usd
CY2021Q3	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-5937	usd
	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	32289	usd
	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-88023	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	32859	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-5937	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	32289	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-88023	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14407214	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25235527	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18375510	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36981697	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15467107	usd
CY2022Q1	crge	Stock Based Compensation Expense Amount StockBasedCompensationExpenseAmount	10743632	usd
CY2022Q1	crge	Declaration Of Preferred Dividends DeclarationOfPreferredDividends	-266984	usd
CY2022Q1	crge	Series C Preferred Stock Member Amount SeriesCPreferredStockMemberAmount	12050000	usd
CY2022Q1	crge	Beneficial Conversion Feature Arising From Preferred Stock Amount BeneficialConversionFeatureArisingFromPreferredStockAmount	2651000	usd
CY2022Q1	crge	Deemed Dividend In Connection With Series C Preferred Stock Amount DeemedDividendInConnectionWithSeriesCPreferredStockAmount	-3856000	usd
CY2022Q1	crge	Common Stock Issued For Acquisition Amount CommonStockIssuedForAcquisitionAmount	17530278	usd
CY2022Q1	crge	Conversion Of Debt Into Common Stock Amount ConversionOfDebtIntoCommonStockAmount	79990	usd
CY2022Q1	crge	Net Loss NetLoss	-13139798	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	41259225	usd
CY2022Q2	crge	Stock Based Compensation Expense Amount StockBasedCompensationExpenseAmount	9342734	usd
CY2022Q2	crge	Declaration Of Preferred Dividends DeclarationOfPreferredDividends	-352827	usd
CY2022Q2	crge	Series D Preferred Stock Amount SeriesDPreferredStockAmount	12498889	usd
CY2022Q2	crge	Common Stock Issued For Private Placement Amount CommonStockIssuedForPrivatePlacementAmount	4695864	usd
CY2022Q2	crge	Issuance Of Warrants For Private Placement IssuanceOfWarrantsForPrivatePlacement	5304161	usd
CY2022Q2	crge	Issuance Of Shares Committed In Prior Period Amount IssuanceOfSharesCommittedInPriorPeriodAmount	0	usd
CY2022Q2	crge	Settlement Of Holdback Shares For Acquisition Amount SettlementOfHoldbackSharesForAcquisitionAmount	1	usd
CY2022Q2	crge	Exercise Of Warrants Amount ExerciseOfWarrantsAmount	1072424	usd
CY2021Q1	crge	Net Loss NetLoss	-1598563	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24795727	usd
CY2021Q2	crge	Shares Of Common Stock From Prior Period Issued Amount SharesOfCommonStockFromPriorPeriodIssuedAmount	0	usd
CY2021Q2	crge	Common Stock Issued For Services Amount CommonStockIssuedForServicesAmount	111555	usd
CY2021Q2	crge	Stock Based Compensation Expense Amount StockBasedCompensationExpenseAmount	9230399	usd
CY2021Q2	crge	Warrants Issued In Connection With Debt WarrantsIssuedInConnectionWithDebt	2654300	usd
CY2021Q2	crge	Derivative Liability Reclassed To Equity DerivativeLiabilityReclassedToEquity	750000	usd
CY2021Q2	crge	Net Loss NetLoss	-10147607	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	27394374	usd
CY2021Q3	crge	Conversion Of Debt And Accrued Interest Amount ConversionOfDebtAndAccruedInterestAmount	291610	usd
CY2021Q3	crge	Common Stock Issued For Services Amount CommonStockIssuedForServicesAmount	75000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	-18119592	usd
CY2022Q2	crge	Exercise Of Stock Options Amount ExerciseOfStockOptionsAmount	20000	usd
CY2022Q2	crge	Vesting Of Restricted Stock Amount VestingOfRestrictedStockAmount	14	usd
CY2022Q2	crge	Conversion Of Series B Preferred Into Common Stock Amount ConversionOfSeriesBPreferredIntoCommonStockAmount	6165000	usd
CY2022Q2	crge	Classification Of Preferred C To Mezzanine Equity Amount ClassificationOfPreferredCToMezzanineEquityAmount	-12684918	usd
CY2022Q2	crge	Deemed Dividend In Connection With Reclass Of Warrants To Derivative Liability DeemedDividendInConnectionWithReclassOfWarrantsToDerivativeLiability	-40442518	usd
CY2022Q2	crge	Stock Issued During Period Amount Other StockIssuedDuringPeriodAmountOther	-1	usd
CY2022Q2	crge	Net Loss NetLoss	-19642927	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7235121	usd
CY2022Q3	crge	Stock Based Compensation Expense Amount StockBasedCompensationExpenseAmount	7824976	usd
CY2022Q3	crge	Restricted Stock Units RestrictedStockUnits	22660	usd
CY2022Q3	crge	Exercise Of Warrants Amount ExerciseOfWarrantsAmount	49777	usd
CY2022Q3	crge	Exercise Of Stock Options Amount ExerciseOfStockOptionsAmount	144077	usd
CY2022Q3	crge	Declaration Of Dividends DeclarationOfDividends	-302441	usd
CY2022Q3	crge	Stock Issued During Period Amount Other StockIssuedDuringPeriodAmountOther	-58282	usd
CY2022Q3	crge	Net Loss NetLoss	14407214	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29323102	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20653095	usd
CY2021Q1	crge	Shares Of Common Stock From Prior Year Issued Amount SharesOfCommonStockFromPriorYearIssuedAmount	0	usd
CY2021Q1	crge	Common Stock Issued For Services Amount CommonStockIssuedForServicesAmount	167348	usd
CY2021Q1	crge	Conversion Of Debt And Accrued Interest Amount ConversionOfDebtAndAccruedInterestAmount	1010650	usd
CY2021Q1	crge	Stock Based Compensation Expense Amount StockBasedCompensationExpenseAmount	4563197	usd
CY2021Q1	crge	Adjustment To Par Value AdjustmentToParValue	0	usd
CY2021Q3	crge	Stock Based Compensation Expense Amount StockBasedCompensationExpenseAmount	7764023	usd
CY2021Q3	crge	Cancellation Of Stock Options CancellationOfStockOptions	-249920	usd
CY2021Q3	crge	Restricted Stock Units RestrictedStockUnits	43514	usd
CY2021Q3	crge	Buyback Of Treasury Stock Amount BuybackOfTreasuryStockAmount	-144871	usd
CY2021Q3	crge	Net Loss NetLoss	-25235527	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9938203	usd
	us-gaap	Net Income Loss NetIncomeLoss	-18407799	usd
	us-gaap	Net Income Loss NetIncomeLoss	-36893674	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1059966	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	usd
	us-gaap	Depreciation Depreciation	685074	usd
	us-gaap	Depreciation Depreciation	314334	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	28351975	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	21351212	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	0	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	353903	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	28669066	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-400	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-7938229	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-2147594	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-95127	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	1140090	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-3420417	usd
	crge	Amortization Of Debts Issue Costs AmortizationOfDebtsIssueCosts	0	usd
	crge	Amortization Of Debts Issue Costs AmortizationOfDebtsIssueCosts	10438	usd
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	110538	usd
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	261432	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
	crge	Other Operating Income Expense Net1 OtherOperatingIncomeExpenseNet1	2465068	usd
	crge	Other Operating Income Expense Net1 OtherOperatingIncomeExpenseNet1	-1268155	usd
	crge	Income Tax Benefit Expense IncomeTaxBenefitExpense	-1772804	usd
	crge	Income Tax Benefit Expense IncomeTaxBenefitExpense	-5908091	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1899791	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	18536022	usd
	crge	Increase Decrease In Accrued Revenue IncreaseDecreaseInAccruedRevenue	0	usd
	crge	Increase Decrease In Accrued Revenue IncreaseDecreaseInAccruedRevenue	-1717395	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-72779	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	14144	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-1761407	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	2258191	usd
	crge	Increase Decrease In Other Assets IncreaseDecreaseInOtherAssets	-43147	usd
	crge	Increase Decrease In Other Assets IncreaseDecreaseInOtherAssets	117476	usd
	crge	Costs In Excess Of Billings CostsInExcessOfBillings	-3041310	usd
	crge	Costs In Excess Of Billings CostsInExcessOfBillings	0	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	10147863	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-11205660	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-1196067	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	424506	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2048463	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	usd
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	usd
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-88023	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2916904	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3502956	usd
	crge	Payment To Acquire Fixed Assets PaymentToAcquireFixedAssets	-204893	usd
	crge	Payment To Acquire Fixed Assets PaymentToAcquireFixedAssets	-1274687	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	837120	usd
	crge	Sale Of Intellectual Property SaleOfIntellectualProperty	179466	usd
	crge	Sale Of Intellectual Property SaleOfIntellectualProperty	0	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	45430216	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	62031435	usd
	crge	Proceeds From Sale Of Marketable Securities ProceedsFromSaleOfMarketableSecurities	47428885	usd
	crge	Proceeds From Sale Of Marketable Securities ProceedsFromSaleOfMarketableSecurities	55872437	usd
	crge	Payments To Acquire Non Marketable Securities PaymentsToAcquireNonMarketableSecurities	0	usd
	crge	Payments To Acquire Non Marketable Securities PaymentsToAcquireNonMarketableSecurities	-100000	usd
	crge	Acquisition Of Ans AcquisitionOfAns	-362962	usd
	crge	Acquisition Of Ans AcquisitionOfAns	-12948324	usd
	crge	Acquisition Of Ev Depot AcquisitionOfEvDepot	-1231250	usd
	crge	Acquisition Of Ev Depot AcquisitionOfEvDepot	0	usd
	crge	Cash Acquired From Acquisition1 CashAcquiredFromAcquisition1	104485	usd
	crge	Cash Acquired From Acquisition1 CashAcquiredFromAcquisition1	-282101	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	483515	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19926990	usd
	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	0	usd
	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	10000000	usd
	crge	Proceeds From Convertible Notes Payable ProceedsFromConvertibleNotesPayable	0	usd
	crge	Proceeds From Convertible Notes Payable ProceedsFromConvertibleNotesPayable	5000000	usd
	crge	Proceeds From Sale Of Common Stock ProceedsFromSaleOfCommonStock	10000025	usd
	crge	Proceeds From Sale Of Common Stock ProceedsFromSaleOfCommonStock	0	usd
	crge	Proceeds From Sale Of Series C Preferred Stock ProceedsFromSaleOfSeriesCPreferredStock	10845000	usd
	crge	Proceeds From Sale Of Series C Preferred Stock ProceedsFromSaleOfSeriesCPreferredStock	0	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1121818	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	164076	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	crge	Draws From Revolving Line Of Credit Net DrawsFromRevolvingLineOfCreditNet	254245	usd
	crge	Draws From Revolving Line Of Credit Net DrawsFromRevolvingLineOfCreditNet	-270727	usd
	crge	Employee Taxes Paid For Stock Based Compensation EmployeeTaxesPaidForStockBasedCompensation	-417959	usd
	crge	Employee Taxes Paid For Stock Based Compensation EmployeeTaxesPaidForStockBasedCompensation	0	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	61232	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	78288	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	81272	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	818343	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	0	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	685000	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20385574	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14586769	usd
	crge	Foreign Currency Adjustment ForeignCurrencyAdjustment	45261	usd
	crge	Foreign Currency Adjustment ForeignCurrencyAdjustment	-366306	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17997446	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2203571	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18238264	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11629303	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36235710	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9425732	usd
	us-gaap	Interest Paid Net InterestPaidNet	2138386	usd
	us-gaap	Interest Paid Net InterestPaidNet	247900	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	485401	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	crge	Issuance Of Series B Preferred Stock For Acquisition IssuanceOfSeriesBPreferredStockForAcquisition	0	usd
	crge	Issuance Of Series B Preferred Stock For Acquisition IssuanceOfSeriesBPreferredStockForAcquisition	6850000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	17530278	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	crge	Debt Discount Associated With Promissory Notes DebtDiscountAssociatedWithPromissoryNotes	0	usd
	crge	Debt Discount Associated With Promissory Notes DebtDiscountAssociatedWithPromissoryNotes	4296911	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 1 Nature of operations</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Charge Enterprises, Inc., through its subsidiaries (sometimes referred to herein as “we,” “us,” “our,” “Charge” or the “Company”) consists of a portfolio of global businesses with a vision to build the electrification and telecommunications infrastructure that will address and service requirements for EVC (“Electrical Vehicle Charging”) and WNI (“Wireless Network Infrastructure”) which includes 5G, tower, distributed antennae systems (“DAS”), small cell, and electrical infrastructure.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company operates in two segments: Telecommunications, which provides connection of voice calls, data, and Short Message Services (“SMS”) to global carriers; and Infrastructure, which builds physical wireless network elements, provides electrical construction services, and installs and maintains EV charging stations and infrastructure. Financial information about each business segment is contained in “Note 14 Reportable segments.”</p>
CY2022Q3	crge	Unrealized Losses UnrealizedLosses	334457	usd
	crge	Net Gains Within Net Income From Investments On Statement Of Operations NetGainsWithinNetIncomeFromInvestmentsOnStatementOfOperations	1215505	usd
	crge	Realized Gains Loss RealizedGainsLoss	226168	usd
	crge	Unrealized Losses UnrealizedLosses	989337	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	1231250	usd
CY2022Q1	us-gaap	Accrued Liabilities Fair Value Disclosure AccruedLiabilitiesFairValueDisclosure	18750	usd
CY2022Q1	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	6827	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	17530278	usd
CY2022Q1	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	18787105	usd
CY2022Q3	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	11924617	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	3026788	usd
CY2022Q3	crge	Mezzanine Equity Net MezzanineEquityNet	16600000	usd
	crge	Assets And Liabilities Measured At Fair Valuetabletextblock AssetsAndLiabilitiesMeasuredAtFairValuetabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="10" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30, 2022</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="10" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, 2021</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 1</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 2</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 3</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 1</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 2</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Level 3</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Assets:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:7pt">Marketable securities (Note 4)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">6,404,567</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">9,618,743</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Liabilities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:7pt">Derivative liabilities (Note 12)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">11,773,452</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:7pt">Contingent consideration</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">3,513,132</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
	crge	Reconciliation Of Changes In Fair Valuetabletextblock ReconciliationOfChangesInFairValuetabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Contingent consideration liability:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:7pt">Balance at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:7pt">Initial estimate upon acquisition</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">79,575</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:7pt">Remeasurement</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3,433,557</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:7pt">Balance at September 30, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">3,513,132</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	usd
	crge	Business Combination Recognized Identifiable Assets Acquired And Liability Assumed Contingent Liability BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilityAssumedContingentLiability	79575	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	3433557	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	3513132	usd
	us-gaap	Dilutive Securities DilutiveSecurities	6451072	usd
CY2021	us-gaap	Dilutive Securities DilutiveSecurities	10549524	usd
	us-gaap	Unrealized Loss On Securities UnrealizedLossOnSecurities	46505	usd
CY2021	us-gaap	Unrealized Loss On Securities UnrealizedLossOnSecurities	930781	usd
	crge	Fair Value Of Assets FairValueOfAssets	6404567	usd
CY2021	crge	Fair Value Of Assets FairValueOfAssets	9618743	usd
CY2022Q3	crge	Net Gains Within Net Income From Investments On Statement Of Operations NetGainsWithinNetIncomeFromInvestmentsOnStatementOfOperations	193131	usd
CY2022Q3	crge	Realized Gains Loss RealizedGainsLoss	527588	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	861222	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	198744	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1059966	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	11924617	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	198746	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	794974	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	794974	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	794974	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	794974	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	794974	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	6691035	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10864651	usd
CY2022Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	12498889	usd
	crge	Accumulated Amortization Deferred Finance Costs1 AccumulatedAmortizationDeferredFinanceCosts1	0	usd
CY2021Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	259835	usd
CY2022Q3	crge	Total total	0	usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	6019	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	95127	usd
CY2020Q3	us-gaap	Shares Outstanding SharesOutstanding	288889	shares
CY2021Q4	crge	Paycheck Protection Program Loan PaycheckProtectionProgramLoan	2000000	usd
CY2021Q4	crge	Notes Payable Issued NotesPayableIssued	11860055	usd
CY2022Q3	crge	Notes Payable Issued NotesPayableIssued	11860055	usd
CY2021Q4	crge	Notes Payable Issued December NotesPayableIssuedDecember	15925926	usd
CY2022Q3	crge	Notes Payable Issued December NotesPayableIssuedDecember	15925926	usd
CY2022Q3	crge	Notes Payable Value NotesPayableValue	27785981	usd
CY2021Q4	crge	Notes Payable Value NotesPayableValue	29785981	usd
CY2022Q3	crge	Unamortized Discount And Debt Issue Cost UnamortizedDiscountAndDebtIssueCost	-5037990	usd
CY2021Q4	crge	Unamortized Discount And Debt Issue Cost UnamortizedDiscountAndDebtIssueCost	-3698458	usd
CY2022Q3	crge	Paycheck Protection Program Loans PaycheckProtectionProgramLoans	2000000	usd
CY2022Q3	crge	Loan Reclassified LoanReclassified	2000000	usd
CY2022Q3	crge	Reimburse Sba Loan ReimburseSBALoan	2000000	usd
	crge	Interest Expense And Amortisation Debt Discount InterestExpenseAndAmortisationDebtDiscount	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended September 30, </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Nine Months Ended September 30, </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Interest expense </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">484,642</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">209,160</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,453,926</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">278,114</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Amortization of debt discount </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">494,561</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">252,039</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,547,207</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">252,039</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">979,203</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">461,199</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">4,001,133</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">530,153</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q3	us-gaap	Interest Expense Other InterestExpenseOther	484642	usd
CY2021Q3	us-gaap	Interest Expense Other InterestExpenseOther	209160	usd
	us-gaap	Interest Expense Other InterestExpenseOther	1453926	usd
	us-gaap	Interest Expense Other InterestExpenseOther	278114	usd
CY2022Q3	crge	Amortization Of Debt Discount And Financing Costs AmortizationOfDebtDiscountAndFinancingCosts	494561	usd
CY2021Q3	crge	Amortization Of Debt Discount And Financing Costs AmortizationOfDebtDiscountAndFinancingCosts	252039	usd
	crge	Amortization Of Debt Discount And Financing Costs AmortizationOfDebtDiscountAndFinancingCosts	2547207	usd
	crge	Amortization Of Debt Discount And Financing Costs AmortizationOfDebtDiscountAndFinancingCosts	252039	usd
CY2022Q3	crge	Debt Discount DebtDiscount	979203	usd
CY2021Q3	crge	Debt Discount DebtDiscount	461199	usd
	crge	Debt Discount DebtDiscount	4001133	usd
	crge	Debt Discount DebtDiscount	530153	usd
CY2022Q3	crge	Accrued Interest Notes AccruedInterestNotes	161547	usd
CY2021Q4	crge	Accrued Interest Notes AccruedInterestNotes	115250	usd
CY2022Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	40400000	usd
	crge	Derivative Deemed Dividend DerivativeDeemedDividend	32800000	usd
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	749600	usd
	crge	Reclassification Of Derivative ReclassificationOfDerivative	40442518	usd
	crge	Reclassification Of Derivative ReclassificationOfDerivative	-749200	usd
	crge	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	-28669066	usd
	crge	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	400	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	18361001	shares
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	11773452	usd
CY2022Q3	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue	1138555	usd
	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue	3549307	usd
CY2022Q3	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	432921	usd
CY2021Q3	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	166431	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1745040	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	314334	usd
	crge	Capital Expenditures CapitalExpenditures	204893	usd
	crge	Total Investments TotalInvestments	6579984	usd
	crge	Total Investments TotalInvestments	9718743	usd
CY2022Q3	us-gaap	Assets Assets	187544458	usd
CY2021Q4	us-gaap	Assets Assets	143609512	usd
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	crge	Outstanding Warrants To Purchase Common Stock OutstandingWarrantsToPurchaseCommonStock	11800000	shares
CY2022Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	40400000	usd
	crge	Deemed Dividend Amount DeemedDividendAmount	32800000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	44920000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.78
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2550000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.47
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	565000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.16
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.06
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	46905000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.85
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	14737501	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.14
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3475000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.00
CY2022Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	10000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.00
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	687500	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.96
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	49682500	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.47
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	985000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.36
CY2022Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	261959	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.55
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	482500	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.46
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	49923041	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.05
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	18797522	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.52
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P4Y8M4D
	crge	Unrecognized Costs Related To Stock Options Granted UnrecognizedCostsRelatedToStockOptionsGranted	31632307	usd
CY2022Q3	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	250000	usd
CY2022Q3	us-gaap	Time Deposit Liability Above Us Insurance Limit TimeDepositLiabilityAboveUsInsuranceLimit	24656441	usd
CY2021Q4	us-gaap	Time Deposit Liability Above Us Insurance Limit TimeDepositLiabilityAboveUsInsuranceLimit	17503737	usd
CY2022Q3	crge	Income Loss Before Income Tax Benefit IncomeLossBeforeIncomeTaxBenefit	14191171	usd
CY2021Q3	crge	Income Loss Before Income Tax Benefit IncomeLossBeforeIncomeTaxBenefit	-27944850	usd
	crge	Income Loss Before Income Tax Benefit IncomeLossBeforeIncomeTaxBenefit	-20180603	usd
	crge	Income Loss Before Income Tax Benefit IncomeLossBeforeIncomeTaxBenefit	-42801765	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	183184	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2715260	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1772804	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5908091	usd
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.013	pure
CY2021Q3	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.097	pure
	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.088	pure
	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.138	pure
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	14071914	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25229590	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-56027370	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-36893674	usd
CY2022Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	2630305	usd
CY2021Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	usd
CY2022Q3	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	11441609	usd
CY2021Q3	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	-25229590	usd
	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	-56027370	usd
	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	-36893674	usd
CY2022Q3	us-gaap	Dividends Dividends	295819	usd
CY2021Q3	us-gaap	Dividends Dividends	0	usd
	us-gaap	Dividends Dividends	0	usd
	us-gaap	Dividends Dividends	0	usd
CY2022Q3	crge	Plus Undistributed Earnings Allocated To Participating Securities1 PlusUndistributedEarningsAllocatedToParticipatingSecurities1	2630305	usd
CY2021Q3	crge	Plus Undistributed Earnings Allocated To Participating Securities1 PlusUndistributedEarningsAllocatedToParticipatingSecurities1	0	usd
	crge	Plus Undistributed Earnings Allocated To Participating Securities1 PlusUndistributedEarningsAllocatedToParticipatingSecurities1	0	usd
	crge	Plus Undistributed Earnings Allocated To Participating Securities1 PlusUndistributedEarningsAllocatedToParticipatingSecurities1	0	usd
CY2022Q3	us-gaap	Undistributed Continuing Operation Earnings Loss Allocation To Participating Securities Diluted UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesDiluted	2392897	usd
CY2021Q3	us-gaap	Undistributed Continuing Operation Earnings Loss Allocation To Participating Securities Diluted UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesDiluted	0	usd
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	6363233	shares
	us-gaap	Undistributed Continuing Operation Earnings Loss Allocation To Participating Securities Diluted UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesDiluted	0	usd
	us-gaap	Undistributed Continuing Operation Earnings Loss Allocation To Participating Securities Diluted UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesDiluted	0	usd
CY2022Q3	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Diluted UndistributedEarningsLossAvailableToCommonShareholdersDiluted	11974836	usd
CY2021Q3	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Diluted UndistributedEarningsLossAvailableToCommonShareholdersDiluted	-25229590	usd
	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Diluted UndistributedEarningsLossAvailableToCommonShareholdersDiluted	-56027370	usd
	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Diluted UndistributedEarningsLossAvailableToCommonShareholdersDiluted	-36893674	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	206224561	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	152222589	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	196126428	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	150397062	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	77088	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	1769884	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	16953621	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	231388387	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	152222589	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	196126428	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	150397062	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	25122445	shares
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	114397192	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	117824281	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	95761896	shares

Files In Submission

Name	View Source	Status
0001654954-22-015114-index-headers.html	Edgar Link	pending
0001654954-22-015114-index.html	Edgar Link	pending
0001654954-22-015114.txt	Edgar Link	pending
0001654954-22-015114-xbrl.zip	Edgar Link	pending
crge-20220930.xsd	Edgar Link	pending
crge_10q.htm	Edgar Link	pending
crge_ex311.htm	Edgar Link	pending
crge_ex312.htm	Edgar Link	pending
crge_ex321.htm	Edgar Link	pending
crge_ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
crge-20220930_cal.xml	Edgar Link	unprocessable
crge-20220930_def.xml	Edgar Link	unprocessable
crge-20220930_lab.xml	Edgar Link	unprocessable
crge-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
crge_10q_htm.xml	Edgar Link	completed
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Charge Enterprises, Inc.

2022 Q4 Form 10-Q Financial Statement

#000165495422015114 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission